US 12371442
Isoindolinone and indazole compounds for the degradation of EGFR
granted A61KA61K31/427A61K31/496
Quick answer
US patent 12371442 (Isoindolinone and indazole compounds for the degradation of EGFR) held by C4 THERAPEUTICS, INC. expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- C4 THERAPEUTICS, INC.
- Grant date
- Tue Jul 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K31/427, A61K31/496, A61K31/506, A61K31/5377